PIMECROLIMUS
Generic: PIMECROLIMUS
Glenmark Pharmaceuticals Inc.Manufacturer
TOPICALRoute
PIMECROLIMUSActive Substance
2019-08-29Original Approval
PIMECROLIMUS is FDA application ANDA211769, sponsored by GLENMARK PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
245 reports
2
DERMATITIS ATOPIC
200 reports
3
PRURITUS
193 reports
4
RASH
183 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
126 reports
6
DRY SKIN
101 reports
7
OFF LABEL USE
101 reports
8
ECZEMA
97 reports
9
SKIN EXFOLIATION
76 reports
10
ERYTHEMA
75 reports